805323-20-0

Basic information

• Product Name: N-[(1E)-(3,4-dimethoxyphenyl)methylene]-2,2-dimethoxyethanamine
• Synonyms: N-[(1E)-(3,4-dimethoxyphenyl)methylene]-2,2-dimethoxyethanamine
• CAS NO: 805323-20-0
• Molecular Weight: 253.298
• Mol File: 805323-20-0.mol

Chemical Properties

• CAS DataBase Reference: N-[(1E)-(3,4-dimethoxyphenyl)methylene]-2,2-dimethoxyethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(1E)-(3,4-dimethoxyphenyl)methylene]-2,2-dimethoxyethanamine(805323-20-0)
• EPA Substance Registry System: N-[(1E)-(3,4-dimethoxyphenyl)methylene]-2,2-dimethoxyethanamine(805323-20-0)

Safety Data

• Hazardous Substances Data: 805323-20-0(Hazardous Substances Data)

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 22483-09-6 2,2-dimethoxyethylamine 

Downstream Products

• 21638-57-3 N-(2,2-dimethoxyethyl)-1-(3,4-dimethoxyphenyl)but-3-en-1-amine 
• 63968-39-8 N-(1-(3,4-dimethoxyphenyl)ethyl)-2,2-dimethoxyethan-1-amine 
• 54879-76-4 N-(3,4-dimethoxybenzyl)aminoacetaldehyde dimethyl acetal 
• 868157-86-2 (3R)-(-)-N-(2,2-dimethoxyethyl)-3-(3,4-dimethoxyphenyl)-3,4-dihydro-1-(2H)-isoquinolone 
• 868157-85-1 (S)-(-)-N-(2,2-dimethoxyethyl)-3-(3,4-dimethoxyphenyl)-1,2,3,4-tetrahydroisoquinoline 
• 868157-88-4 (R)-(+)-N-(2,2-dimethoxyethyl)-3-(3,4-dimethoxyphenyl)-1,2,3,4-tetrahydroisoquinoline 
• 868157-83-9 (3S)-(+)-N-(2,2-dimethoxyethyl)-3-(3,4-dimethoxyphenyl)-3,4-dihydro-1-(2H)-isoquinolone 

Relevant articles and documents

LiCl-mediated preparation of highly functionalized benzylic zinc chlorides

In the presence of zinc dust (1.5-2.0 equiv) and LiCI(1.5-2.0 equiv), various benzylic chlorides bearing functional groups (iodide, cyanide, ester, ketone) are smoothly converted at 25°C to the corresponding zinc reagents without homo-coupling (≤5%). The utility of these benzylic zinc reagents is demonstrated by a short synthesis of papaverine.

Transformation of (+)-thiomicamine into a new ligand for the enantioselective addition of methyllithium to prochiral imines

A new ligand 2 was prepared from (+)-thiomicamine 1 and o-methoxyphenol, and its activity as an external controller of stereochemistry in enantioselective additions of methyllithium to prochiral imines 8-10 tested. The non-racemic secondary amines 11-13 w

5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them

A 5,10-dihydroimidazo[2,1-b]quinazoline in which at least one ring carbon atom, other than the carbon atom in the 2-position, bears a substituent, or a pharmaceutically acceptable acid addition salt thereof is a useful cardiotonic agent and vasodilator in heart insufficiency and a blood platelet aggregation inhibitor.